This report focuses on the global Rx Medical Food status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rx Medical Food development in United States, Europe and China. Medical food is a category of products for dietary management or supportive therapy for specific disease or medical conditions such as pulmonary and metabolic disorders. Ingredients used in medical foods must have generally recognized as safe (GRAS) status, which is assigned to naturally found food materials. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine. These products are prescribed by physicians or taken under their supervision. Growing regulatory support, increasing awareness about medical food in emerging economies and advantages over drug therapies are expected to be the major factors driving growth of the global Rx medical food market over the forecast period. In 2017, the global Rx Medical Food market size was 15500 million US$ and it is expected to reach 26700 million US$ by the end of 2025, with a CAGR of 7.0% during 2018-2025. The key players covered in this study Abbott Laboratories Danone Mead Johnson & Company, LLC. Fresenius Kabi AG Nestle Primus Pharmaceuticals, Inc. Targeted Medical Pharma Pivotal Therapeutics Enzymotec Ltd. AlfaSigma Market segment by Type, the product can be split into Pills Powders Liquids Others Market segment by Application, split into Pain Management Sleep Disorder Neurological Disorder GI Disorder Pulmonary Disorders Metabolic Disorders Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Rx Medical Food status, future forecast, growth opportunity, key market and key players. To present the Rx Medical Food development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Rx Medical Food are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Rx Medical Food Market Size Growth Rate by Type (2013-2025) 1.4.2 Pills 1.4.3 Powders 1.4.4 Liquids 1.4.5 Others 1.5 Market by Application 1.5.1 Global Rx Medical Food Market Share
